Stryker (SYK) Change in Receivables (2009 - 2026)
Stryker's (SYK) quarterly Change in Receivables came in at -$444.0 million in Q1 2026, down 208.33% year-on-year from $409.8 million in Q1 2025, and down 211.84% on a QoQ basis from $397.0 million in Q4 2025.
Stryker (SYK) Change in Receivables (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Change in Receivables data on file, last reported at -$444.0 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 208.33% year-over-year to -$444.0 million in Q1 2026; TTM through Mar 2026 was -$427.0 million, a 198.16% decrease from a year earlier, with the FY2025 full-year figure at -$127.0 million, down 139.56% from the prior year.
- Change in Receivables for Q1 2026 stood at -$444.0 million, down from $397.0 million in the prior quarter.
- Over the last five years, Change in Receivables for SYK reached as high as $441.0 million in Q4 2023 and fell as low as -$444.0 million in Q1 2026.
- Historically, Change in Receivables has averaged $29.6 million across 5 years, with a median of $36.0 million in 2024.
- Across the five-year window, Change in Receivables jumped 171.93% in 2024 and sank 841.67% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $393.0 million in 2022, then advanced by 12.21% to $441.0 million in 2023, then dropped by 12.02% to $388.0 million in 2024, then grew by 2.32% to $397.0 million in 2025, then sank by 211.84% to -$444.0 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$444.0 million in Q1 2026, $397.0 million in Q4 2025, and -$267.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 123.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -444.00 Mn |
| Mar 31, 2026 | -444.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Mar 31, 2024 | -258.00 Mn |
| Mar 31, 2024 | -258.00 Mn |
| Dec 31, 2023 | 441.00 Mn |
| Dec 31, 2023 | 441.00 Mn |